Eric Thomas Schmidt, Chief Financial Officer at Allogene Therapeutics, Inc. (ALLO), sold 59,600 shares at $32.40 ($1.9M) on 2021-01-15, disclosed to the SEC on 2021-01-19.
Open-market sale of $1.9M ALLO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.60 | 9,851 | $301K | 16.1% |
| 2 | $30.60 | 9,851 | $301K | 16.1% |
| 3 | $31.10 | 5,149 | $160K | 8.5% |
| 4 | $31.10 | 5,149 | $160K | 8.5% |
| 5 | $31.69 | 3,547 | $112K | 6.0% |
| 6 | $31.69 | 3,547 |
| $112K |
| 6.0% |
| 7 | $32.40 | 11,053 | $358K | 19.1% |
| 8 | $32.40 | 11,053 | $358K | 19.1% |
| 9 | $33.29 | 400 | $13K | 0.7% |
| Total | $31.50 avg | 59,600 | $1.9M | 100% |
| Filing → |
| ALLO | SELL | 2020-11-18 | $644K | — | Filing → |
| ALLO | SELL | 2020-10-16 | $1.2M | — | Filing → |
| ALLO | SELL | 2020-09-22 | $944K | — | Filing → |